Lifelong Montrealer Susan Kahn has dedicated her career to helping people who experience
thrombosis, from those diagnosed with cancers to young women that are pregnant or
taking the contraceptive pill and experiencing deep vein thrombosis (DVT) or pulmonary
embolism (PE). Kahn s kind demeanour and patience for explaining complicated concepts
is obvious as she speaks to The Lancet Haematology. Today, she is a Professor of Medicine
at McGill University (Montreal, QC, Canada) and is based at the affiliated Jewish
General Hospital, where she founded, and is Director of, the Centre of Excellence
in Thrombosis and Anticoagulation Care (CETAC).
Article content
Saying the AstraZeneca vaccine is safe and effective against COVID-19, a world expert in thrombosis is seeking to reassure Montrealers who might be worried about developing blood clots.
“Blood clots actually occur at a far higher rate in the general population than among people who have received the AstraZeneca vaccine,” Dr. Susan Kahn, the director of the Centre for Excellence in Thrombosis and Anticoagulation Care at the Jewish General Hospital, said in a statement Monday.
We apologize, but this video has failed to load.
Try refreshing your browser, or Montreal blood-clot expert seeks to quell fears about AstraZeneca vaccine Back to video